Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Sarcopenia 2Colorectal Neoplasms 2Colonic Neoplasms 2Stomach Neoplasms 1Seaweed Associated Changes in Healthy Subjects 1Rectal Neoplasms 1Prostatic Neoplasms 1Multiple Myeloma 1Mucositis 1Lymphoma 1Head and Neck Neoplasms 1Diarrhea 1Cholangiocarcinoma 1Chemotherapy-related Diarrhea 1

Interventions

Cyclophosphamide 18fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Cyclosporine 12Whole-Body Irradiation 11Antilymphocyte Serum 10fludarabine 9Exercise 9Busulfan 9Mycophenolic Acid 8Melphalan 8Dexamethasone 8Blood Specimen Collection 8Filgrastim 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6Therapeutics 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5Surveys and Questionnaires 4Stem Cell Transplantation 4Psychiatric Rehabilitation 4Practice Guidelines as Topic 4Methylprednisolone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Multiple Myeloma × maltodextrin × Clear all
NCT05135351 2026-04-20

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

University of Nebraska

Phase NA Recruiting
30 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡